Harvest One Provides Notice of Mandatory Conversion of...

Harvest One Provides Notice of Mandatory Conversion of Convertible Debentures
February 23, 2018 17:39 ET | Source: Harvest One Cannabis Inc.


VANCOUVER, British Columbia, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Harvest One Cannabis Inc. (TSXV:HVT) ("Harvest One" or the "Company") is pleased to announce that it has provided notice to holders of the Company's 8.0% unsecured convertible debentures expiring December 14, 2022, listed on the TSX Venture Exchange under the trading symbol HVT.DB (the "Debentures") that Harvest will be exercising its option to convert the entire principal amount of Debentures outstanding plus accrued interest thereon into common shares of the Company ("Common Shares") at a price of $0.84 (the "Mandatory Conversion"). Pursuant to the terms of a debenture indenture entered into by the Company and Computershare Trust Company of Canada dated February 14, 2017, filed under the Company's issuer profile on www.sedar.com, if, at any time, the volume weighted average price of the Common Shares on the TSX Venture Exchange for 30 consecutive trading days shall equal or exceed $1.40, the Company may elect to exercise its right of Mandatory Conversion. The Mandatory Conversion is expected to be completed on or about March 28, 2018.

About Harvest One Cannabis Inc. (TSXV:HVT)Harvest One is a global cannabis company focused on delivering high quality, innovative cannabis products and technology to regulated markets around the world. Our shareholders have significant exposure to the entire cannabis value chain through three business units, with Harvest One serving as the parent company over horticultural arm United Greeneries and medical arm Satipharm AG. Harvest One’s businesses are all strategically located in favourable jurisdictions with supportive regulatory frameworks in place. United Greeneries has a Canadian ACMPR cultivation and sales license, making Harvest One a unique global company with the capacity to commercially cultivate and sell medicinal grade cannabis in a federally regulated environment.

Colin Clancy
Communications
1-877-915-7934
[email protected]

---------------------------------------------------------------
Immediate thoughts

1) the move to convert is a shrewed one. This saves $1.6m a year in interest payments and conserves cash. If this was not converted then up to 2022 this would have cost 6.4mio.(please check me on this)

2) while there could be selling pressure after 28 march when this closes, its not necessarily dillutive! Remember the company received 20mio in return for the right to issue shares at a later date. So debt decreases as shares increase.

3) overall I take it positively that the interest saved will go towards building capacity and decreases overhang in future on potential conversions. The slim premium right now at 1.16 vs 0.84c would discourage some from selling off the bat and that to me is a shrewed and good move.

4) impact on mmj would be minimal unless HVT declines tremendously from a mass selldown when this closes on 28 mar onwards.